Preoperative and Postoperative Endoscopic Alterations in Patients Submitted to Gastric Bypass Without a Ring
NCT ID: NCT03106207
Last Updated: 2017-04-10
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
30 participants
INTERVENTIONAL
2013-10-01
2016-12-05
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Laparoscopic Sleeve Gastrectomy: a Cohort Study
NCT03629808
Very Long Term Results After Laparoscopic Retrocolic Antegastric Gastric Bypass
NCT01040507
Effect of Laparoscopic Sleeve Gastrectomy Versus Roux-en-Y Gastric Bypass on Gastroesophageal Reflux Disease: An 8-Year Prospective Cohort Study
NCT03692455
Regain Rate According to gj Anastomosis Size in Gastric Bypass
NCT05655975
Weight Loss Following Gastric Bypass or Sleeve Surgery
NCT02070081
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Organization and infrastructure: This study is organized based on a single location: the Kaiser Clinic and Day Hospital. This center is renowned for the treatment of diseases in the areas of Gastroenterology, Proctology and General Surgery.
Objectives:
General: Demographic, clinical, nutritional, operative and endoscopic data will be assessed.
Specific: The objective of this research will be to investigate preoperative and postoperative endoscopic changes in patients undergoing gastric bypass without a ring.
Patients and Methods: Thirty obese patients from different regions of the country with surgical indication for the Roux-en-Y gastric bypass will be studied prospectively. Patients who meet the inclusion criteria will be invited to participate and, on agreeing, they will sign Informed Consent Forms. The procedures will be performed only after patients give their written consent.
Clinical evaluation of the patients Clinical history: Patients will be questioned about the frequency and intensity of their symptoms. Commonly used medications will be noted as well as drugs used for symptomatic relief (number of tablets). Any urgent/emergency events (such as emergency room visits and/or hospital admission) will be investigated. Other clinical events will also be recorded.
Physical examination:A physical examination (general and gastroenterological) will be performed routinely in all patients participating in this study.
Procedures in the pre- and post-procedure phases: Patients will be submitted to a UGE before the gastric bypass surgery without a ring. All changes related to the esophageal body, distal esophagus and stomach will be analyzed. Biopsies will be performed of the distal esophagus (two fragments 4 cm above the esophagogastric transition), gastric body (anterior and posterior walls), incisura angularis and gastric antrum (large and small pre-pyloric curvature). Furthermore, biopsies will be performed of any lesions detected in the esophagus or stomach.
All patients will be submitted to UGE two, six and 12 months after the surgical procedure. The following will be performed in postoperative endoscopies:
1- The mucosa of the esophageal body will be studied, biopsies of the distal esophagus (two fragments) and small curvature (two fragments) will be performed and the gastric pouch width and anteroposterior diameter and length of the small curvature will be evaluated; 2 - the shape of the gastrojejunal anastomosis will be evaluated and the maximum diameter will be measured and 3 - the jejunal loops will be studied in relation to mucosal changes and afferent loop size and angulation.
All exams will be performed at the Kaiser Clinic after patients have fasted for at least eight hours and signed an informed consent form for the UGE. With the patient in left lateral decubitus position, 10% xylocaine spray will be instilled followed by 50 mcg fentanyl EV and 5 mg midazolam EV. After sedation, an Olympus CV 180 endoscope (Olympus, Tokyo, Japan) will be introduced orally. The images obtained will be transferred to a Olympus EVIS EXERA II processor connected to a computer unit with the ZScan 5 program (Zscan Software Ltda, Goiânia, Brazil). When the patient regains his level of consciousness, he will be released in the company of a responsible adult.
Postoperative clinical evaluation: After hospital discharge, all patients should return for outpatient follow-ups including a clinical evaluation and endoscopy exams.
Clinical visits will be scheduled as follows:
Visit 1 - 2 months; Visit 2 - 6 months; Visit 3 - 12 months
Clinical complications / adverse events / clinical outcomes: For all patients, any possible clinical complication will be promptly checked by the principal investigator.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
NA
SINGLE_GROUP
TREATMENT
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Upper gastric endoscopy (UGE)
Patients will be submitted to a UGE before the gastric bypass surgery without a ring and at two, six and 12 months after the surgical procedure .
Upper gastric endoscopy (UGE)
UGE will be performed before the gastric bypass surgery and post-surgery at two, six and 12 months of clinical visit.
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Upper gastric endoscopy (UGE)
UGE will be performed before the gastric bypass surgery and post-surgery at two, six and 12 months of clinical visit.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Patients with indication for gastric bypass without ring;
* Patient attending regular appointments in the Gastroenterology Service.
Exclusion Criteria
* Patients who have no indication of gastric bypass without a ring;
* Pregnant women (a BHCG test will be required from all women of childbearing age).
18 Years
65 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Kaiser Clinic and Hospital
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Luiz Gustavo de Quadros, MD
Role: PRINCIPAL_INVESTIGATOR
Kaiser Clinica and Day Hospital
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Kaiser Clinic and Day Hospital
São José do Rio Preto, São Paulo, Brazil
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
KaiserCDH
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.